Author Instructions
Overview
Innovative Publication is a publisher of open-access journals. All
submitted manuscripts are managed by Manuscript Peer-Review
Process called MPRP as
a rapid and rigorous double-blind peer-reviewed, manuscript handling, and
editorial process. In this platform, all authors, reviewers, editors, and
editorial office works on a single platform.
A manuscript submission checklist is
necessary during the final submission of an article before sending it to the
journal for the peer-review process.
One author should be designated as the
Corresponding author with complete contact details.
The author should check the Aims and
Scope of the journal.
Use the MS Word template to prepare your
manuscript.
An author should ensure about Authorship
Criteria, Research and Publication Ethics, Manuscript Preparation,
Authorship, Copyright, Format, Figure, Data, and reference format have been
appropriately considered.
The author has approved the content of
the submitted manuscript.
All necessary files have been uploaded, and
contain Keywords, figures, and captions, all tables (including title,
description, and footnotes).
The manuscript has been spell-checked and
grammar-checked.
The author has obtained copyright material
permission.
Manuscript
Submission Process
All manuscripts must be submitted online at www.mprp.in. The submitting author, who
is generally the corresponding author, is responsible for the manuscript during
the submission and peer-review process. The submitting author must ensure that
all eligible co-authors have been included in the author list read the authorship
qualify criteria and that they have all read and approved the
submitted version of the manuscript, To submit your manuscript, first-time users
click the register button from the submission
portal. On successful registration, you will receive an email verification mail
and after confirmation, you will be able to log in as an author you can directly
log in by using your credentials (Username-Registered mail ID & Password)
or you can directly Sign in with Google or ORCID ID.
After successful registration, log in as an
author and post your manuscript for further processing. While submitting,
the author is required to provide information on payment and possible funder
agreements. During submission of the funder, details ensure you meet all your
funder requirements.
Manuscript
Preparation
Title
Page Information: Manuscripts must be prepared in
accordance with Manuscript Title, Author list, affiliations, abstract, and
Keywords.
Original
Research Manuscript: Introduction, Materials and
Methods, Results, Discussion, Figures, Tables, Conclusions, etc.
Author
Ethical Responsibilities: The author should provide
Supplementary Materials, Acknowledgements, Author Contributions, Conflicts of
Interest, Funding, Data Availability Statement, and Citations.
Presentation
and Format: Spacing, Margins, Page Numbering,
Words limit, etc.
Cover
Letter
Cover Letters must be included with each
manuscript submission and it should be concise and explain why the content of
the paper is significant and find the context of existing work. It should
explain the manuscript is suitable for the scope of the journal. The cover letter
should prove the following details:
Manuscript Title
Type of Manuscript
Authors full names (First name, Middle Name,
and Last Name)
Complete Affiliations (in sequences)
Contact no and email id
ORCID iD/Researcher’s profile
Title
Page Information
The Title page should carry
The title of your manuscript should be
concise, specific, relevant, and informative that contain the major keywords,
formulae, and abbreviations avoided.
Running title or short title, not more than 6
words.
Authors’ first and last names must be
provided. The initials of any middle name can be added. The standard format
used for PubMed/MEDLINE for affiliations is complete address information
including city, pin/zip code, state, and country. The affiliations should be
given as 1, 2, and 3 but not marked with symbols.
Clearly indicate who will be the
Corresponding author and handle all stages of communication for pre-publication
and post-publication of the manuscript. Ensure that the name address, phone
number, and e-mail address of the contributor responsible for correspondence
about the manuscript. Contact details must be up to date and the institutional
e-mail address and contact number of the corresponding author. Please read the Authorship
qualify criteria.
Original
Research Article
Structured
Abstracts: The abstract should be provided with a
maximum of 150 -250 words with subheadings: Background, Methods, Results,
Conclusion, and Keywords.
Background: The background for the study should state the study’s purpose,
basic procedures, main findings and principal conclusions. It should emphasize
new and important aspects of the study and observation.
Methods: Methods describe briefly the main methods or treatments applied
and include relevant preregistration numbers and species and strains of any
animals used.
Results: Results are presented in logical sequence in table, text, and figures,
giving the main and most important findings. Emphasize or summarise only the
most important observations, do not use replicate all the data, tables,
figures, and text. Summarize the article’s main findings only.
Conclusion: conclusion indicates the interpretations with the goal of the
study but avoids unqualified statements and the abstract should be an objective
representation of the article. It must not consider results that are not
presented and substantiated in the main text and should not exaggerate the main
conclusions.
Keywords: Keywords need to be added after the abstract and we recommended
that the keywords are specific to the article and within the subject
discipline. Keywords are used for indexing purposes and abbreviations
established in the field may be eligible.
Acknowledgements: Acknowledgement of grants, funds, person, and support in a
separate section at the end of the article before the reference and include
them on the title page as a footnote to the title or otherwise.
Introduction: The introduction should `be briefly placed in a broad context
and highlight why it is important. It should define the purpose of the work and
its significance including specific and previous studies in the area. The
current state of the research clearly described the purpose of the study, the
tested hypothesis, and its aim and scope. Finally, briefly mention the main aim
of the work and highlight the main conclusions. Keep the introduction
comprehensible to scientists working outside the topic of the research paper.
Materials
and Methods: The Methods section should only
include information that was available at the time the study was planned or the
protocol written; all information obtained during the conduct of the study
belongs to the results section. New methods and protocols should be described
in detail while well-established methods can be briefly described and
appropriately cited. Give the name and version of any software used and make
clear where the computer code used is available. A statement indicating that
the research was approved by an independent local, regional and national level.
Results: Provide a concise and precise description of the experiment
results and data on all primary and secondary outcomes, identified in the
materials and method part and do not include methods, discussion and
conclusions. All Charts, figures, and Tables are cited in text in numerical
order and include a brief description, consider using supplement material to
use and major findings.
Discussion: The author should discuss the results and how they can be
interpreted from the perspective of previous studies and of the working
hypotheses. The finding and their implications should be discussed in the
broadest context possible and limitations of the work highlighted and further
research directions may be mentioned. Explore the implications of findings for
further research and policy and combined them with results.
Conclusions: This section is crucial and required as it summarize the key
points and findings of your paper. It determines overall conclusions of the
study and the future research directions.
Patents: It is not mandatory but may be updated if there is patent work reported
in this manuscript.
Manuscripts submitted to the Annals of Geriatric Education and Medical
Sciences that is not original articles must come into one of the
following categories:
Review Articles
Case Report/Case Series
Letter-to-Editor
Short Communication/Commentary
Editorial/Others
Review Article:
It is expected that review articles are
written by individuals who have done substantial work on the subject or are
considered experts in the field. Review articles should address a focused topic,
issue, or question. They should be balanced and up-to-date. They should not
simply restate the literature but rather interpret and integrate the findings
to provide a framework for understanding the literature on a particular topic.
A short summary of the work done by the authors in the field of review should
accompany the manuscript. The author submitting a review article should include
a section describing the methods used for locating, selecting, extracting, and
synthesizing data. Methods should be summarized in the form of an abstract.
Structure: Abstract, Keywords, Introduction, Discussion, Conclusion
and References
The discussion part of the review should be
managed into sub-division headed by informative sub-titles. We welcome review
articles on journal subjects but the above topics' content should be discussed
with the Editors prior to submission indicating how this manuscript would be
different from recent review manuscripts in the field.
Case Report / Case Series:
Authors should submit new, interesting, and
rare case reports/case series. They should be unique, describe a great
diagnostic or therapeutic challenge, and provide a learning point for readers.
Cases with clinical significance or implications will be given priority. Case
reports do not require extensive patient details and should be submitted as
Correspondence. Correspondence should not contain more than 800 words.
Letter-to-Editor:
Letters to the editor should be focused on
news or on an article that has been published in a journal within the previous
year. The letter should focus on an important aspect of the paper that is in
the author’s opinion and its comments.
Editorial,
Short Communication, Commentary, and other: as
mentioned below.
|
Article Types: |
Detail Descriptions |
|
Original Research Article |
Words limit: 2000-4500
(Excluding references) Structured Abstracts: Aim
& Objective, Background/Introduction, Material & Methods, Results,
Conclusion, and Keywords (150 -250 Words) Keywords: (3-10) References: Minimum
- 15 and Maximum – 70 Maximum Number of Figures: 8 (Quality: Pixel 300 DPI) Maximum No of Table: 8 Article explanation:
Introduction, Materials and Methods, Results, Discussion, Conclusions |
|
Review Article |
Words limit: 2500-6000
(Excluding references) |
|
Headings: Abstract,
Keywords, Introduction, Discussion, Conclusion, and References |
|
|
Maximum Number of Figures: 8 (Quality: Pixel 300 DPI) Maximum No of Table: 8 |
|
|
References: Minimum
- 15 and Maximum - 100 |
|
|
Case Report/Case Series |
Words limit: 1000-
2500 Excluding references |
|
Main Headings: Abstract,
Introduction, Case Presentation/Series, Discussion, Conclusion, and Reference |
|
|
Figures: 5-15
(Quality: Pixel 300 DPI) Table: 3-8 |
|
|
References: In
between 8-25 |
|
|
Letter-to-Editor |
Words limit: Up
to 300-600 words |
|
Short Communication/Commentary |
Words limit: Up
to 600-1500 References: In
between 5-15 |
|
Editorial/Guest Editorial/others |
Words limit: Up
to 300 – 1000 |
|
Author Ethical Responsibilities |
Provide
Supplementary materials, Acknowledgements, Conflicts of Interest, Funding
Source, Data Availability Statement, and Citations, Clinical Trial
Registry, Acknowledgments |
Manuscript
Presentation and Formatting: All manuscript
content should follow the given formatting style
Manuscripts should be submitted in Microsoft
Word (Ms-Word) only, No PDF or other format is allowed.
Use normal plain font (e.g. 12-point, Times
New Roman) for text.
Use double-space for all text, including
abstract, table, reference, footnotes, and figure legends.
Use italics for emphasis
Page margins 1.00 from all four sides
Page numbers at the bottom
Keywords (3-10)
Reference according to the journal
instructions, punctuation marks checked
Submission of the manuscript without track
changes
If any brand name is cited, provide the brand
name, address, city, etc.
Use the table function in Word, not
Spreadsheet/excel, to create a table
All tables (including title, description, and
footnotes)
Sharp and clear Figures/graphics
All figure captions
Save your file in Docx format (Ms-word 2007
or higher)
All scientific names should be written in
italics
Measurement of Units: Internationally
accepted rules, regulations, policies, and conventions use the International
System of Units (SI). If any other units are mentioned please provide their
equivalent SI
Files for figures and tables must be provided
during submission in a single zip/WinRAR file and archives and at a clear and
high-resolution pixels width/height, or a resolution of 300 dpi (Dots Per Inch)
or higher. Standard formats are accepted and preferred as TIFF, JPEG, EPS, and
PDF.
Authors are encouraged to prepare tables and
figures in colour (RGB at 8-bit).
Figures include photographs, radiographs, or
micrographs and include only essential figures and use composite figures
containing several panels of photographs.
All Figures, tables, and artworks should have
a short explanatory title and caption and all table columns should have an
explanatory heading. To facilitate the copy-editing of large tables smaller
fonts may be used. The author should use the Table option of Ms-Word to create
a table.
Tables always are cited in text in
consecutive numerical order and each table supplies a table caption (title)
explaining the components of the table.
Identify any previously published material by
giving the original source in the form of a reference at the end of the table
caption. All experiment samples and controls used for one comparative analysis
are run on the same pattern.
You should check figures for duplications and
ensured the figures are clear and accurate.
Supplementary
Materials: It describes any supplementary material
published online alongside the manuscript (figure, table, spreadsheet, video,
etc.). The author should indicate the name and title of each element as follows
Figure S1: title, Table S1: Title, etc.
Funding
and Acknowledgments: This may include administrative
and technical support or donations in kind of people, grants, funds, etc.
should be placed in a separate section on the title page of the manuscript and repeated
before references.
In addition please provide the funding
information in a separate step while submitting of manuscript process. If the
funding institution you need is not listed, it can be entered as text. Funding
information will be published as searchable metadata for the accepted article,
where acknowledgments are published on the page.
Author
Contributions: Authors are required to include
a statement of responsibility, to have made substantial contributions to the
conception or design of the work, or the acquisition, analysis, or
interpretation of the data or drafting the work and substantively revising it.
Authorship must include and be limited to those who have contributed
substantially to the work.
Data
Availability Statement: Provide details regarding
where data supporting reported results can be found, including links to
publicly archived datasets analysed or generated during the study or you might
choose to exclude this statement if the study did not report any data.
Conflicts
of Interest: Authors must disclose any
financial and personal support or interest that may be recognized and determine
the representation or interpretation of reported research results. Potential
conflicts of interest include employment, consultation, ownership, honorarium,
patent application, testimony, etc. Any project funded by the industry
must pay special attention to the full declaration of funder involvement. If
there is no role, please state the sponsors had no role in the design,
execution, recognition, or writing of the study. According to The
International Committee of Medical Journal Editors (ICMJE), authors
should avoid signing into any agreements with study sponsors, both for-profit
and non-profit, that interface with the author’s access to all of the study’s
data or that interface with their ability and interpretation of data and
publish manuscripts independently when they select. For more details
visit Conflict
of Interest.
The statement should reflect all the collected potential conflict of interest
disclosures in the form. If no conflicts exist, the authors should state.
Conflicts
of Interest: The authors declare no
conflicts of interest.
References: Reference must be numbered in order of appearance in the text
(including figure, captions table, and legends) and listed individually at the
end of the manuscript. The reference style can be learned from reading past
issues of this journal. Text citation of the reference in number at the end of
a sentence or at the end of a clause that requires a literature citation.
Original research is limited to 35 references and there are no limits in the
number of references for review articles. We recommended preparing the
reference with bibliography software like Zotero, EndNote, etc. to avoid typing mistakes
and duplicated references. We encourage citations to data, other citable and
research material.
Citation: Reference and Citation in supplementary files are permitted and
provided that they also appear in the main text and in the reference list in
order
Journal is committed to accepting open
scientific exchange and enabling our authors to achieve best practices in
sharing and archiving research data. We encourage all authors of articles
published with Innovative Journal to share their research data. Every journal
guideline can be found in the journal “Instructions for
Authors” Policy of data sharing concerns the minimal dataset support
and findings of a published study. Collected data should be publically
available and cited in accordance with the guidelines of the journal.
Publication data policies
Before submission of research datasets as
electronic supplementary material, authors should read the journals. We
encourage research data to be archived in data repositories wherever possible.
The author should ensure that the data shared are in accordance with the
consent provided by participants on the use of confidential data. Availability
of data statement provided regarding where the data reporting and supported
result can be found including publically archived dataset analyzed and
generated during the study.
Data availability and suggested statements
are mentioned below:
Journal encourages authors to provide
articles with an external database that helps to build a better understanding
of time to explain the research.
Publicly available data accessible in the
repository
Data presented in the study are openly
available in (repository name e.g. Fig Share) at (DOI), reference number
(reference number).
Datasets are assigned DOI
A data repository may be cited in the
reference list. Data citations should include the minimum information
recommended by DataCite: Authors, title, publisher (repository name), and
identifier.
Available data on request due to restriction
e.g. Ethical or privacy
Presentation of data in this study is
available on request from the corresponding author, the data are not publicly
available due to (mention the reason).
Third-Party Data
Restrictions apply to the availability of
these data. Data were obtained from (third party) and are available (from the
authors/website) with the permission of (third party).
Data sharing is not applicable
New data sharing was created or analyzed in
this study is not applicable to the article.
Data Citation:
(dataset) Authors. Year. Dataset title,
repository data or archives, Version (if available); Persistent identifier
(e.g., DOI).
Supplementary
Material and References
While submission of the manuscript additional
data and files can be uploaded as “Supplementary Files”. Supplementary files
will also be available to the referees as part of the peer-review process. Any
additional files and format is acceptable. We recommend that non-proprietary
and common formats are used where possible. References and citations in
supplementary files are permitted provided that they also appear in the main
text and in the reference list.
Unpublished
and Research Data Policy
Data restrictions availability should be
noted during submission and in the manuscript. Authors are encouraged to
publish all observations related to the submitted manuscript as supplementary
material as Unpublished data. Data submission to the journal implies that
materials described in the manuscript, including all relevant raw data, will be
freely available to any researcher wishing to use them for non-commercial
purposed, without breaching participant confidentiality. We encourage authors
to ensure that their datasets are either deposited in publically available
repositories or presented in the main manuscript or additional supporting files.
Journal accepts all sequence names and the
accession numbers provided by the databases must be provided in the material
and methods section of the article.
Research
Ethics Involving Human, Animal, and Plants
When reporting studies on human
subjects indicate whether the procedures followed were in accordance with
the ethical standards of the responsible committee on human experimentation
(institutional or regional) and with the Helsinki Declaration of 1975, as revised
in 2000 (available at https://www.wma.net/what-we-do/medical-ethics/declaration-of-helsinki/doh-oct2000/).
Do not use patients’ names, initials, or hospital numbers, especially in
illustrative material. Written consent for publication must be signed by
participating patients with information. Related data to participants must be
explained in detail, and personal information of patients need not be disclosed
unless it is an identifiable matter is of relevance to the research like
patients' photographs, or faces that show particular complications. Patients’
particulars or other identification need not appear in any form of images.
A manuscript that includes any case details,
like personal information and images of patients, authors must obtain signed
informed consent for publication from patients or relatives/guardians before
submitting to Innovative Publication journal. Details of the patient must be
anonymous as for as possible, e.g. do not mention age, ethnicity, occupation,
or relations if they are not relevant to the conclusions. An available Patient
Permission Template form for Download. A plain version of the
form used to obtain permission without the patient's name or signature must be
uploaded with your submission. The editor reserves the right to reject any
submission that does not meet these criteria.
The author may refer to using our sample form
and provide an appropriate form after consulting with your affiliated
institution for the purposes of publishing with us. Journal and Consent,
permission, or release form should include unlimited permission for publication
in all formats like online, print and online, and print format, in sublicensed
and reprinted versions and other works and products under open access license.
The publisher does not prescribe the kinds of contributions that all license
authorship. It is recommended that authors adhere to the guidelines for
authorship that are applicable in their specific research field.
The submitted manuscript will be checked by
the editorial office or on request of documentary evidence related to discuss
documents. When studies describe groups by race, gender, disability, disease,
religion, etc., an explanation regarding why such categorization was needed
must be clearly stated in the article.
Statement
on the Welfare of Animals Rights
When animals used for research must be
respected in reporting experiments on animals, authors should indicate where
the national and international institutional guidelines for the care and use of
animals have been followed, and that the studies have been approved by a
research ethics committee at the institution or practise at which the studies
were conducted. Please provide the name of the ethics committee and the
relevant permit number.
If articles do not contain studies with human
participants or animals by any of the authors, the statement should be as below:
Informed consent if the research involved
human participants, and statement on the welfare of animals if the research
involves animals.
Research involving animals and their data or
biological materials, utilization of plants, fungi, algae etc.
The author will be held responsible for false
statements or failure to fulfil the guidelines on animals and humans.
Refinement of experimental conditions and
procedures to minimize the harm to animals.
Authors must consider details on husbandry,
housing, and pain management in their manuscript.
The reference list should include the full
title, as recommended by the ACS style guide. Style files for Endnote and
Zotero are available. Reference should be described and depending on the types
of the work, which is mentioned as below:
For
Journal Article
The surname is followed by the first
initials. (et al. after six authors). Article title. Title of the
journal with a standard abbreviation. Year of publication; Volume (Issue
number): Pages.
Example:
Choudhury DD, Sonawane JP, Chowdhary A. The
study of prevalence of needle stick and sharp injuries among healthcare workes
in tertiary care hospital, Navi Mumbai. IP
Int J Med Microbiol Trop Dis. 2021;7(4):227-31.
Onweh DA, Edeogu CO, Okezie AO, Ogbodo EC,
Nwanguma DE, Oguaka VN et al. Effect of trace elements in the immune system of
pregnant women attending antenatal clinic in alex ekwueme federal university
teaching hospital. J Community Health
Manag. 2021;8(4):181-9.
For Book
The surname is followed by the first
initials. Book title. Edition (if applicable). Place: Publisher; Year.
Example:
Jena S, Kumar G. Advanced Diagnostic
Techniques for Oral Cancer Detection. 1st ed. New Delhi: IP Innovative
Publication; 2022.
For Book
Chapter
The surname is followed by first initials.
Title of the chapter. In: Surname editor Initial(s), editor. Book title.
Edition (if available). Place: Publisher; Year. Pages.
Example:
Bomzon PS. Tree Diversity in Indian Forests.
In: Laha J, Chakravort P, Mukherjee D, Sinha NK, Mukherjee R, Samanta AK.
Forestry in India-An overview. New Delhi: IP Innovative Publication; 202 p.
34-58.
For E-Book
The surname is followed by first initials.
Book title [Internet]. Place: Publisher; Year [cited date]. Available from: URL.
Example:
Bareja R. Practical Medical Microbiology for
BMLT [Internet]. New Delhi: IP Innovative Publication; 2021 [2022 Jan 15].
Available from: https://www.wonderslate.com/Practical Medical Microbiology for
BMLT/ebook?siteName=books&bookId=26316
Conference
Proceeding Papers
The surname is followed by first initials.
Title of paper. In: Surname editor Initial(s), editor. Title of the conference.
Place: Publisher; Year. Pages.
Example:
Venkatesh A. Role of Human Resources in
Organizational Innovation for sustainability of New Business. In: Lohara J.
2nd International Conference on Innovation and Sustainability of New
Businesses. New Delhi: IP Innovative Publication; 2019. p- 216-9.
Newspaper
Articles
The surname is followed by first initials.
(if available). Title of article. Title of newspaper. Date: Pages (if
available).
Example:
Coronavirus in India live updates: Delhi
reports 57 new cases, zero deaths in last 24 hours. The Times of India. Sep 15,
202
Thesis Unpublished:
Author; The surname is followed by first
initials. Title of Thesis (Type of Thesis). Location of University: University
Name; Year.
Example:
Joy L. Prevalence and antibiogram of
burkholderia species isolated from tertiary care hospital (Research). Kerala: Jubilee Mission Hospital; 202
Thesis Published:
Author; The surname is followed by first
initials. Title of Thesis (Type of Thesis). Place of Publication: Publisher
Name; Year of Publication.
Example:
Joy L. Prevalence and antibiogram of
burkholderia species isolated from tertiary care hospital (Research). New
Delhi: IP Innovative Publication; 202
Website
Author; The surname is followed by first
initials. Title [Internet]. Place: Publisher; Date of publication [updated
date; cited date]. Available from: URL.
Example:
Donovan R. Everything You Need to Know About
Heart Disease. [Internet]. New York: Healthline; Updated on 2020 February
27. Available from: https://www.healthline.com/health/heart-disease
Always use the standard abbreviation of the
journal’s name according to the ISSN number and list of titles Word
Abbreviations check. If you are unsure, please use the full journal title.
We recommend that clinical trials are
prospectively registered in a public domain database and clinical trial
registration numbers should be mentioned in all papers that report their
results. Authors are asked to provide the name of the trial register and the
clinical trial registration number in the manuscript. If a clinical trial is
not registered or registered retrospectively, the reason must be provided at
the time or before the time of the patient first enrolment as a condition of
consideration for publication.
Journal follows the International
Committee of Medical Journal Editors (ICMJE) guidelines. We
strongly encouraged authors to pre-registration clinical trials with
international clinical trials register and cite a reference to the registration
in the method section. A suitable database must be included and requires a
complete consolidation of standard reporting trials as per CONSORT minimum
guidelines for publication. Suitable databases include http://ctri.nic.in/Clinicaltrials/login.php and
those listed by the World Health Organization International
Clinical Trials Registry Platform
Authors are required to submit approval to
conduct a study from a local and independent, regional, national authority.
Journal reserves the right to reject a paper without trial registration for
further peer-review process. Reports of randomized clinical trials should
present information on all major studies, including the protocol, assignment of
interventions, based on the CONSORT
statement.
Specific
Study Designs and Reporting Guidelines
Journal requires a complete CONSORT
2010 Checklist key document and CONSORT
2010 flow diagram, as a condition of submission of reporting
the results of the randomized clinical trial. The author can find templates of
these reporting guidelines on the CONSORT website www.consort-statement.org. Authors are also
referred to the EQUATOR network for
further information on the available reporting guidelines for health research.
Various other checklists are available for various study designs. We encourage
our authors to follow the guidelines of SAGER's “Sex and Gender
Equity in Research” rationale for the SAGER guidelines and recommend use
whenever it is relevant. Authors should describe in the background, whether sex
and gender differences may be expected. If sex and gender analysis were not
conducted, the rationale should be given in the discussion part. Journal
suggest the author follow full guidelines
of SAGER.
The journal will follow the COPE guidelines on
how to handle the potential acts of misconduct of publication ethics.
Authors must follow the submission
guidelines of the journal.
Authors must ensure that the work they are
submitting as their manuscript is entirely original. Authors must certify that
the manuscript has not previously been published elsewhere. Authors sign a
declaration stating that the manuscript and the illustrations within are
original, or that he/she has taken all necessary steps to avoid breach of
copyright.
Submitting the same paper to more than one
journal constitutes unethical publishing practice. The author submitting the
manuscript to the journal ensures that all contributing co-authors and no
uninvolved person(s) are included in the author list.
Authors must notify the editors of any
conflicts of interest that may be construed to influence the manuscript.
Authors are obliged to provide retractions or corrections of mistakes at any
point in time if the author(s) discovers a significant error or inaccuracy in
the submitted manuscript.
Data and methods used in the research need to
be presented in sufficient detail in the paper so that other researchers can
replicate the work.
A single study should not be split up into
several parts to increase the number of submissions and submitted to various
journals or to one journal.
Results should be presented clearly, and
honestly, without any falsification or fabrication of data.
Plagiarism manipulation and data fabrication
are not allowed.
Plagiarism is not acceptable including
copyright, text ideas, image from another source, or even from your own
published content without giving any credit to the original source. To
steal and pass off the ideas or words of another as one’s own, use another’s
production without crediting the source” or “present as new and original an
idea or product derived from an existing source”. We consider “self-plagiarism”
as a form of plagiarism. Self-plagiarism would be when an author borrows from
his or her own previously published work without the proper citation within the
newly submitted manuscript. We use iThenticate software
to check plagiarism. If plagiarism is found or noticed from other sources, the
editorial board should check the status. If the plagiarism is confirmed as an
intentional thing, then the following actions will be carried out. This should
be reported to the editorial board, authors and corresponding authors and all
authors' names will be marked as the blacklist.
After submission of a manuscript, please
suggest any two potential reviewers with the appropriate expertise to review
the manuscript. The editors will not necessarily approach these referees.
Please provide details information after the completion of the manuscript
submission like Name, E-mail id, contact number and homepage. The proposed
reviewer should be from a different institution to the authors or the author
may identify appropriate Editorial Board members of the journal as potential
reviewers. You may suggest reviewers from among the authors that you frequently
cite in your paper.
It is necessary that the submitted manuscript
is grammatically correct in the English language. We suggest authors facilitate
proper peer-reviewing of your manuscript. If you need help with writing in
English or are not a native English speaker, we suggest that you have your
manuscript professionally edited before submission or read by a native
English-speaking colleague. Using a professional English language editing
service where editors will improve the English to ensure that your meaning is
clear and identify problems that require your review. These services can be
carried out by Innovative Author Services. Professional editing will enable
reviewers and future readers to easily read and assess the content of submitted
manuscripts. All accepted manuscripts undergo language editing, however, a fee
will be charged to the author if very extensive English correction must be made
by Editorial Office: Pricing is according to the services.
The journal and publisher assume all authors
agreed with the guidelines International
Committee of Medical Journal Editors (ICMJE) which state that
all given explicit consent to the manuscript submission and that they obtained
consent from the authors’ responsibilities at the institution where the work
has been carried out. The publisher does not prescribe the role of
contributions that authorship. Those who contributed to the work but did
not qualify for authorship should be listed in the acknowledgements.
Any updates on the author list should be
approved by all authors including any who have been removed from the list.
The corresponding author should act as a point of contact between the
editor and the other authors and should keep co-authors informed and involve
them in minor decisions about the publication. The publisher reserve the right
to request confirmation that all authors meet the authorship conditions.
Visit for more details about authorship check
the Innovative
Publication ethics website.
The author has the right to send an appeal to
the editorial office of the journal by sending an e-mail. The appeal must
provide a detailed justification, including all point-by-point responses to the
reviewer's and or Editor's comments. Expert advisory recommendations on the
manuscript may recommend acceptance, for further peer review, or uphold the
original rejection decision. A reject decision at this stage is final and
cannot be reserved.
Once the manuscript gets accepted, will
process for a professional copy-editing team, English editing, proofreading by
the authors, final correction, pagination and publication on the journal
website www.agems.in
Editorial Process and Peer-Review
Primary
Scrutiny
All submitted manuscripts received by the
manuscript submission portal will be scrutinised by the Editorial office to
determine whether they are properly prepared and whether they follow the
editorial policies of the journal, taking care of human, animal and plant
experimentation. The manuscript that does not suitable with the journal's
ethics policy or does not meet the standards of the journal will be rejected
before peer review. The manuscript that is not properly prepared will be
returned to the authors for revision and resubmission. After these checks, the
Managing Editor will consult the journals, Editor-in-Chief or Associate Editors
to identify whether the manuscript is suitable for the scope of the journal and
whether it is scientifically acceptable. There is no judgement on the potential
impact of the work that will be made at this stage.
Peer-Review
When the submitted manuscript crosses primary
scrutiny, the editorial office team assigned to at least two independent
experts for peer review. In the case of regular submissions, in-house assistant
editors will invite experts, including recommendations by an academic editor.
Potential reviewers suggested by the authors may also be considered. Reviewers
should not be published with any of the co-authors during the past three years
and should not currently work or collaborate with any of the institutions of
the co-authors of the submitted manuscript.
All the submitted manuscripts, reviews and
communication are managed by the Pre-Publication Portal of the
journal/peer-review system. The manuscript peer-review process receives at
least two reviews. The editorial office team will communicate the decision to
editors and inform the author.
All review comments should be responded to
via the pre-publication portal. When the author disagrees with a reviewer, they
must provide a clear response.
Peer-Review
Duration
The Journal follows the ideal average
duration between the submission and publication of an article. The first
decision after submission will be taken within 1–5 days and will be informed to
the authors. We generally take 7–24 days for the peer-review process. Apart
from this, the publication time is 45–60 days after the submission of an
article by an author. It may vary on the basis of many factors like article
type, the journal’s internal process, and the availability of peer-reviewers
along with authors, reviewers, and editorial staff communications.
The corresponding author will receive one
print copy of the issue. If the corresponding author or any other authors are
looking for an additional hard copy they can order from the editorial office at
the Individual price of a single issue. The publisher and the society are not
responsible for providing additional copies if the original is lost.
To support the Author in the submission of
articles, please visit the journal homepage. For details instructions on
preparation of the submission of the manuscript. Please visit https://www.ipinnovative.com/contact-us,
contact details for a query after acceptance of an article visit www.mprp.in, you can check our author FAQ at https://www.ipinnovative.com/content/FAQs/313 or
write us: support@ipinnovative.com
visit for Training and Support
If you need assistance with the submission of
your manuscript at our online submission portal, please contact editorialoffice@ipinnovative.com.